FACTIVE

This brand name is authorized in Brazil, Ecuador, Mexico, South Africa, Tunisia, Turkey.

Active ingredients

The drug FACTIVE contains one active pharmaceutical ingredient (API):

1	Gemifloxacin UNII X4S9F8RL01 - GEMIFLOXACIN MESYLATE
	Gemifloxacin is a quinolone that has in vitro activity against a wide range of Gram-negative and Gram-positive microorganisms. Gemifloxacin acts by inhibiting DNA synthesis through the inhibition of both DNA gyrase and topoisomerase IV (TOPO IV), which are essential for bacterial growth.

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
FACTIVE Tablet	MPI, US: SPL/Old	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01MA15	Gemifloxacin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01M Quinolone antibacterials → J01MA Fluoroquinolones
Discover more medicines within J01MA15

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	500511801116215, 500511802112213
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	5097-MEE-0420
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	229M2006
TN	Direction de la Pharmacie et du Médicament	6653511
TR	İlaç ve Tıbbi Cihaz Kurumu	8699514097587, 8699514097594
ZA	Health Products Regulatory Authority	35/20.1.1/0058